Page 141 - IJB-10-3
        P. 141
     International Journal of Bioprinting                               New challenges in liver tissue engineering
            properties, printability, and functionality to promote   References
            hepatic functions. Dynamic culture in bioreactors or
            in microfluidic chip devices equipped with micro-  1.   Pimpin L, Cortez-Pinto H, Negro F, et al. Burden of liver
            physiological  stimulation will  play a  key  role  in drug   disease in Europe: epidemiology and analysis of risk factors to
            screening and liver disease modeling and could pave the   identify prevention policies. J Hepatol. 2018;69(3):718-735.
            way for clinical applications. 5                      doi: 10.1016/j.jhep.2018.05.011
                                                               2.   Karlsen  TH, Sheron  N, Zelber-Sagi S,  et  al. The  EASL–
            Acknowledgments                                       Lancet Liver Commission: protecting the next generation
                                                                  of  Europeans  against  liver  disease  complications  and
            None.                                                 premature mortality. Lancet. 2022;399(10319):61-116.
                                                                  doi: 10.1016/S0140-6736(21)01701-3
            Funding                                            3.   Kaur S, Kidambi S, Ortega-Ribera M, et al. In vitro models
            This work was funded by the Institute of Health Carlos III   for the study of liver biology and diseases: advances and
            (ISCIII, Plan Estatal de I+D+i 2013-2016) and co-financed   limitations. CMGH. 2023;15(3):559-571.
            by the European Regional Development Fund “A way to      doi: 10.1016/j.jcmgh.2022.11.008
            achieve Europe” (FEDER) through Grant No. PI21/00223,   4.   Godoy P, Hewitt NJ, Albrecht U, et al. Recent advances in 2D
            and by Grants PID2022-136433OB-C21 and C-22 funded    and 3D in vitro systems using primary hepatocytes, alternative
            by MCIN/AEI/10.13039/501100011033 and Grant No.       hepatocyte  sources  and  non-parenchymal liver  cells and
                                                                  their use in investigating mechanisms of hepatotoxicity, cell
            CNS2022-135425. The funders had no role in the design   signaling and ADME. Arch Toxicol. 2013;87(8):1315-1530.
            of the study; in the collection, analyses, or interpretation of      doi: 10.1007/s00204-013-1078-5
            data; in the writing of the manuscript; or in the decision to
            publish the results.                               5.   da Silva Morais A, Vieira S, Zhao X, et al. Advanced
                                                                  biomaterials and processing methods for liver regeneration:
                                                                  state‐of‐the‐art and future trends.  Adv Healthc Mater.
            Conflict of interest                                  2020;9(5).
            The authors declare no conflicts of interest.         doi: 10.1002/adhm.201901435
                                                               6.   Ming Z, Tang X, Liu J, Ruan B. Advancements in research
            Author contributions                                  on constructing physiological and pathological liver models
                                                                  and their applications utilizing bioprinting technology.
            Conceptualization: Gloria Gallego-Ferrer, Laia Tolosa  Molecules. 2023;28(9):3683.
            Formal analysis:  Julio Rodríguez-Fernández,  M. Teresa      doi: 10.3390/molecules28093683
               Donato, Gloria Gallego-Ferrer, Laia Tolosa      7.   Michalopoulos GK, DeFrances MC. Liver regeneration.
            Funding acquisition:   M. Teresa Donato, Gloria Gallego-  Science. 1997;276(5309):60-66.
               Ferrer, Laia Tolosa                                doi: 10.1126/science.276.5309.60
            Visualization:  Julio Rodríguez-Fernández, Gloria Gallego-  8.   Kholodenko IV, Yarygin KN. Cellular mechanisms of liver
               Ferrer, Laia Tolosa                                regeneration and cell-based therapies of liver diseases.
            Writing – original draft:  Julio Rodríguez-Fernández, M.   Biomed Res Int. 2017;2017:1-17.
               Teresa Donato, Gloria Gallego-Ferrer, Laia Tolosa     doi: 10.1155/2017/8910821
            Writing – review & editing: Julio Rodríguez-Fernández, M.   9.   Chawla S, Das A. Preclinical-to-clinical innovations in stem
               Teresa Donato, Gloria Gallego-Ferrer, Laia Tolosa  cell therapies for liver regeneration. Curr Res Transl Med.
            All authors have read and agreed to the published version   2023;71(1):103365.
               of the manuscript.                                 doi: 10.1016/j.retram.2022.103365
            Ethics approval and consent to participate         10.  Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of
                                                                  liver diseases in the world. J Hepatol. 2019;70(1):151-171.
            Not applicable.                                       doi: 10.1016/j.jhep.2018.09.014
                                                               11.  Burton R, Henn C, Lavoie D, et al. A rapid evidence
            Consent for publication                               review of the effectiveness and cost-effectiveness of
                                                                  alcohol control policies: an English perspective.  Lancet.
            Not applicable.                                       2017;389(10078):1558-1580.
                                                                  doi: 10.1016/S0140-6736(16)32420-5
            Availability of data
                                                               12.  Hart CL, Morrison DS, Batty GD, Mitchell RJ, Smith GD.
            Not applicable.                                       Effect of body mass index and alcohol consumption on
            Volume 10 Issue 3 (2024)                       133                                doi: 10.36922/ijb.2706
     	
